Vor Biopharma (VOR)
18.94
0.00 (0.00%)
Upcoming Events
Latest Headlines
Telitacicept shows kidney function benefit in two-year IgA nephropathy trial
October 22, 2026 4:05 PM - StreetInsider
Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA Nephropathy
October 22, 2026 4:05 PM - Globe NewsWire
William Blair Starts Vor Biopharma, Inc. (VOR) at Outperform
October 21, 2026 6:02 AM - StreetInsider
U.S. biotech SMids: Q3 earnings preview
October 18, 2026 8:00 PM - StreetInsider
Form 4 Vor Biopharma Inc. For: Oct 02 Filed by: Kolchinsky Peter
October 5, 2026 6:53 PM - SEC Filing
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 5, 2026 6:00 PM - Globe NewsWire
Telitacicept Demonstrates Deep and Durable Minimal Symptom  Expression Through 48 Weeks in Generalized Myasthenia Gravis
September 29, 2026 8:05 AM - Globe NewsWire
Vor Biopharma (VOR) Reiterated at Buy by Stifel on Telitacicept’s Potential for gMG
September 28, 2026 7:40 AM - StreetInsider
Form 4 Vor Biopharma Inc. For: Aug 24 Filed by: Kolchinsky Peter
September 18, 2026 12:40 PM - SEC Filing
This biotech stock still Wolfe's top pick as multiple catalysts loomh
August 31, 2026 8:00 AM - StreetInsider
Form 4 Vor Biopharma Inc. For: Aug 24 Filed by: RA Capital Healthcare Fund LP
August 26, 2026 6:29 PM - SEC Filing
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.
August 14, 2026 4:58 PM - SEC Filing
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Frazier Life Sciences Public Fund, L.P.
August 14, 2026 4:32 PM - SEC Filing
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: Verve Capital Ltd
August 13, 2026 4:31 PM - SEC Filing
Form 10-Q Vor Biopharma Inc. For: Jun 30
August 11, 2026 9:31 AM - SEC Filing
Vor Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 11, 2026 9:30 AM - Globe NewsWire
Form SCHEDULE 13G/A Vor Biopharma Inc. Filed by: FMR LLC
August 7, 2026 11:15 AM - SEC Filing
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: FMR LLC
August 6, 2026 10:44 AM - SEC Filing
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 3, 2026 4:30 PM - Globe NewsWire
Form SCHEDULE 13G Vor Biopharma Inc. Filed by: BlackRock, Inc.
July 30, 2026 11:20 AM - SEC Filing
Full Article List
